Silexion Therapeutics (SLXN) Exchange Rate Effect (2023 - 2026)
Silexion Therapeutics (SLXN) posted quarterly Exchange Rate Effect of -$14000.0 for Q1 2026, down 40.0% year-over-year from -$23333.3 in Q1 2025, and down 180.0% quarter-over-quarter from -$5000.0 in Q4 2025.
Silexion Therapeutics (SLXN) Exchange Rate Effect (2023 - 2026) Analysis & Trends
Silexion Therapeutics' Exchange Rate Effect history runs 4 years deep, the most recent figure standing at -$14000.0 for Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 40.0% year-over-year to -$14000.0; the TTM figure through Mar 2026 stood at -$6000.0 (up 60.0% YoY), while the FY2025 annual figure was -$2000.0, up 96.72% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$14000.0, down from -$5000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $94000.0 in Q4 2023, with the low at -$277000.0 in Q2 2023.
- The 4-year median for Exchange Rate Effect is -$10500.0 (2024), against an average of -$27166.7.
- The sharpest annual moves came in 2024 and 2025: Exchange Rate Effect slumped 111.7% in 2024, then jumped 173.68% in 2025.
- Silexion Therapeutics' Exchange Rate Effect stood at $94000.0 in 2023, then slumped by 111.7% to -$11000.0 in 2024, then surged by 54.55% to -$5000.0 in 2025, then sank by 180.0% to -$14000.0 in 2026.
- Business Quant data shows SLXN's Exchange Rate Effect at -$14000.0 in Q1 2026, -$5000.0 in Q4 2025, and -$1000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Silexion Therapeutics | 266,692.97 | -1.96 Mn | - | 8,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8,000.00 |
| Jun 30, 2026 | 8,000.00 |
| Mar 31, 2026 | -14,000.00 |
| Mar 31, 2026 | -14,000.00 |
| Dec 31, 2025 | -5,000.00 |
| Dec 31, 2025 | -5,000.00 |
| Sep 30, 2025 | -1,000.00 |
| Sep 30, 2025 | -1,000.00 |
| Jun 30, 2025 | 14,000.00 |
| Jun 30, 2025 | 14,000.00 |
| Mar 31, 2025 | -10,000.00 |
| Mar 31, 2025 | -10,000.00 |
| Dec 31, 2024 | -11,000.00 |
| Dec 31, 2024 | -11,000.00 |
| Sep 30, 2024 | 25,000.00 |
| Sep 30, 2024 | 25,000.00 |
| Jun 30, 2024 | -19,000.00 |
| Jun 30, 2024 | -19,000.00 |
| Mar 31, 2024 | -56,000.00 |
| Mar 31, 2024 | -56,000.00 |